X-25012937-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_139058.3(ARX):c.1058C>T(p.Pro353Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P353R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_139058.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARX | NM_139058.3 | c.1058C>T | p.Pro353Leu | missense_variant | 2/5 | ENST00000379044.5 | NP_620689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARX | ENST00000379044.5 | c.1058C>T | p.Pro353Leu | missense_variant | 2/5 | 1 | NM_139058.3 | ENSP00000368332.4 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1091876Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 359060
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 1 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 13, 2002 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Aug 29, 2019 | This variant was identified as hemizygous - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.1058C>T (p.P353L) alteration is located in exon 2 (coding exon 2) of the ARX gene. This alteration results from a C to T substitution at nucleotide position 1058, causing the proline (P) at amino acid position 353 to be replaced by a leucine (L). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant was reported as hemizygous in multiple individuals and de novo in one individual with features consistent with ARX-related neurodevelopmental disorders (Strømme, 2002; Parrini, 2017; Wu, 2019; Yao, 2021). Of note, this variant has also been reported as heterozygous in females with non-syndromic intellectual disability (Wu, 2019). Two other alterations at the same codon, c.1058C>G (p.P353R) and c.1057C>T (p.P353S), have been detected in individuals with lissencephaly, ambiguous genitalia, epileptic encephalopathy, epileptic spasms, clonic seizures, severe developmental delay/intellectual disability, hypotonia, and/or spasticity (Kato, 2004; Papuc, 2019). This amino acid position is highly conserved in available vertebrate species. In vivo functional studies indicate this variant results in an increased susceptibility to seizures in a knock-in mouse model (Kitamura, 2009). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. - |
Corpus callosum agenesis-abnormal genitalia syndrome;C0796244:Intellectual disability, X-linked, with or without seizures, arx-related;C0796250:Partington syndrome;C1846171:X-linked lissencephaly with abnormal genitalia;C3463992:Developmental and epileptic encephalopathy, 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+PS3_Moderate+PS4+PP1_Strong+PM6_Supporting - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at